From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Business Type
Division of Top-10 pharmaceutical manufacturer
Functional Area
Pricing Policy and Analytics for Managed Care
Challenge
Historically, Managed Care pricing decisions were made based on highly subjective information and emotion, not “fact based” on historic customer and contract performance. This was due in part to data that was so limited and inaccurate that often the customer was contacted to “see how are we doing.” As a result, members of the Pricing Committee realized that this environment was leading to substantial inefficiencies and marginal rebate investments with its managed care customers. We were brought in to help integrate managed care data and optimize rebate investments.
Business Challenges
Solution
We helped the manufacturer analyze approximately two years of data for its dominant brand, comprising more than 12 strategic PBMs and/or HMOs within the managed care market. Our team was supplied with imperfect internal data from the Excel worksheets and manually loaded it into our business tool. Analysis of third-party claims data served as a second validation that there were changes that needed to be made. Once the business parameters were defined, key accounts were then prioritized based on business variables, not emotion. Results
By implementing our Rational Pricing methodology, the manufacturer was able to identify accounts that were underperforming from a market share and rebate investment perspective. We also developed best practice structures for the manufacturer resulting in a more manageable, efficient contact decision-making process.
Key Takeaways